New York, July 19, 2018: The Global In Vitro Diagnostics IVD Market is expected to exceed more than US$ 77 billion by 2022 and will grow at a CAGR of more than 5% in the given forecast period.
The Global In Vitro Diagnostics IVD Market is segmented on the lines of its product, technique, application, end user and regional. Based on product segmentation it covers reagents, instruments and software & services. Technique segmentation is further classified into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry and other IVD techniques. Immunodiagnostics is classified into enzyme-linked immunosorbent assay, enzyme-linked immunospot, rapid tests, western blot and radioimmunoassay. Under molecular diagnostics segmentation it covers polymerize chain reaction, hybridization, isothermal nucleic acid technology, microarray, DNA diagnostics and others. Clinical Chemistry is segmented into basic metabolic panel, lipid profile, liver panel, electrolyte panel, thyroid function panel and specialty chemicals. Based on application segmentation it covers infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases and other indications. Under end user segmentation it covers standalone laboratory, hospitals, academic &medical schools, point of care and others.
In vitro diagnostics (IVD) is the approach in which scientific devices and reagents are used to take a look at specimens. Such as blood, urine, stool, tissues and other frame fluids, which can be derived from the human body to detect illnesses, situations and infections? The tests can be carried out in hospitals, standalone laboratory based lab. Number of the giant technology included in vitro diagnostics include polymerase chain reaction (pcr), sequencing technology, microarray techniques and mass spectrometry, which might be used for take a look at sample instruction. Incessant improvements in IVD product design and generations have endorsed medical doctors and researchers to shift their awareness from traditional diagnostic strategies to customized drug treatments.
You Can Find Full Report @: https://www.marketresearchengine.com/reportdetails/global-in-vitro-diagnostics-ivd-market
The major driving factors of Global In Vitro Diagnostics IVD Market are as follows:
• Increasing demand for technically advanced diagnostic devices
• Technical expansion to develop high sensitivity point of care hematology testing
• Improved disposable income of customers gives high expansion potential for IVD market
The restraining factors of Global In Vitro Diagnostics IVD Market are as follows:
• Strict government rules
• Inauspicious reimbursement policies
This report provides:
1) An overview of the global market for In Vitro Diagnostics IVD and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for In Vitro Diagnostics IVD.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The scope of the report includes a detailed study of global and regional markets for Global In Vitro Diagnostics IVD Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Affymetrix, Inc., AlereInc, Biomerieux, Danaher Corporation., Roche Diagnostics, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Abbott Laboratories, Bayer AG., Arkray, Inc., Sysmex Corporation, Johnson & Johnson Pvt. Ltd. And Siemens AG. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Global In Vitro Diagnostics IVD Market has been segmented as below:
The Global In Vitro Diagnostics IVD Market is Segmented on the lines of Product Analysis, Technique Analysis, Application Analysis, End User Analysis and Regional Analysis. By Product Analysis this market is segmented on the basis of Reagents, Instruments and Software & Services. By Technique Analysis this market is segmented on the basis of Immunodiagnostics its covers Enzyme-Linked Immunosorbent Assay (ELISA), Enzyme-Linked ImmunoSpot (ELISPOT), Rapid Tests, Western blot and Radioimmunoassay (RIA). Blood Testing, Molecular Diagnostics its covers Polymerize Chain Reaction (PCR), Hybridization, Isothermal Nucleic Acid Technology (INAAT), Microarray, DNA diagnostics and Others. Tissue Diagnostics, Clinical Chemistry its covers Basic metabolic panel, Lipid profile, Liver panel, Electrolyte panel, Thyroid function panel and Speciality chemicals. And Other IVD Techniques.
By Application Analysis this market is segmented on the basis of Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases and Other Indications. By End User Analysis this market is segmented on the basis of
Standalone Laboratory sector, Hospitals sector, Academic & Medical Schools sector, Point of Care sector and Others sectors. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
5.2.1 Market Drivers
220.127.116.11 Rising Incidence of Chronic Lifestyle Diseases
18.104.22.168 Increasing Adoption of Point-Of-Care Testing
22.214.171.124 Growing Awareness of Personalized Medicine
126.96.36.199 Growth in the Number of Private Diagnostic Centers
5.2.2 Market Restraints
188.8.131.52 Inadequate Reimbursement
184.108.40.206 Rising Healthcare Costs and Low Budgets
5.2.3 Market Opportunities
220.127.116.11 Introduction of A New Range of Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
18.104.22.168 Emerging Economies With Increasing Investments
22.214.171.124 Growing Significance of Companion Diagnostics
5.2.4 Market Challenges
126.96.36.199 Stringent Regulatory Framework
188.8.131.52 Operational Barriers for the Use of Diagnostic Tests
6 Industry Trends
7 Global In Vitro Diagnostics Market, By Product & Service
8 Global In Vitro Diagnostics Market, By Technology
9 Global In Vitro Diagnostics Market, By Application
10 Global In Vitro Diagnostics Market, By End User
11 Global In Vitro Diagnostics Market, By Region
12 Competitive Landscape
13 Company Profiles
13.2 ABBott Laboratories, Inc.
13.3 Becton, Dickinson and Company
13.4 Biomérieux SA
13.5 Bio-Rad Laboratories, Inc.
13.6 Danaher Corporation
13.7 Johnson & Johnson
13.8 Roche Diagnostics
13.9 Siemens AG
13.10 Sysmex Corporation
13.11 Thermo Fisher Scientific, Inc.
13.12 Ortho-Clinical Diagnostics, Inc.
13.13 Qiagen N.V.
13.14 Diasorin S.P.A.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States